Abstract
Background: The use of commercial tinctures for the design of a formulation with
improved anti-microbial activity in a polyherbal lozenge dosage form has not been described.
Objective: This study aimed to develop and evaluate the antimicrobial activity of a novel polyherbal
lozenge formulation containing Ashwagandha, Neem, and Tulsi tinctures in a single-dose
administration. According to previous studies, each of these herbs could be used in herbal medicine
to provide relief from infection owing to their antimicrobial activity, besides other properties,
such as anticancer, antidiabetic, etc.
Methods: The lozenges were prepared using the molding method using three concentrations (1,
3, and 5 % w/w) of commercialized herbal tinctures. Then, they were studied using different
assays, including those designed to evaluate physical properties, stability, and antimicrobial activity.
Results: B4, containing 5% w/w of each tincture, showed the highest antimicrobial activity compared
with the other batches. This batch exhibited the highest value of bacterial inhibition (17.1
± 0.07 mm), according to the agar well diffusion method, including Escherichia coli as a test
microorganism. Hence, B4 was chosen for additional analyses, including physical properties and
stability tests. The results followed Indian Pharmacopeia standards and ICH guidelines, respectively.
The formulation was stable after 2 weeks, and no significant changes were observed in
its physical properties or antimicrobial activity.
Conclusion: This study shows that polyherbal lozenges have anti-microbial activity, with a disintegration
period of 3.86 ± 0.07 minutes in the B4 batch.
Keywords:
Polyherbal lozenges, chemical constituents, soft lozenges formulation, evaluation tests, well diffusion method, antimicrobial activity, stability studies.
Graphical Abstract
[1]
Kamboj, P.; Handa, U.; Nagpal, K.; Dhiman, S.; Guarve, K. Effectiveness of herbal tinctures formulated into lozenges: a current stipulation in pediatric patients. Int. J. Early Childhood Special Educ., 2022, 14(5), 1913-1919.
[5]
Rehman, H.; Zahoor, A.; Shaikh, Z.A.; Naveed, S.; Usmanghani, K. Polyherbal extract based linkus lozenges for symptomatic relief: Design, development, and evaluation. Am. J. Adv. Drug Deliv., 2017, 5(1), 1-18.
[9]
Das, L.; Gunindro, N.; Ghosh, R.; Roy, M.; Debbarama, A. Mechanism of action of Azadirachta Indica Linn. (Neem) aqueous leaf extract as hypoglycaemic agent. Ind. Med. Gaz., 2014, 1, 29-32.
[12]
Modyala, D.; Aparna, C.; Srinivas, P. Formulation, evaluation and characterization of itraconazole lozenges. J. Pharm. Biol. Sci., 2014, 9, 86-94.
[14]
Kaur, Phytochemical analysis and antimicrobial activity of Withania somnifera against Oral Pathogens. J. Pharm. Bioallied Sci., 2019, 11(Suppl. 2), S316-S320.
[15]
Biswas, Biological activities and medicinal properties of neem (Azadirachta indica). Curr. Sci., 2002, 82(11), 1336-1345.
[23]
Verma, S.K.; Kumar, A. Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian J. Pharm. Clin. Res., 2011, 4(1), 1-4.
[36]
Kumar, K.P.; Bhowmik, D.; Tripathi, K.K.; Chandira, M. Traditional Indian herbal plants tulsi and its medicinal importance. Res. J. Pharmacog. Phytochem., 2010, 2(2), 93-101.
[38]
Mishra, S.K. A Review Paper on Tulsi Plant (Ocimum sanctum L.). J. Emerg. Technol. Innov. Res., 2022, 9(1), g515-g524.
[39]
Khaladkar, A.S.; Avalaskar, A.; Bharati, P.; Honkalas, K. Formulation and evaluation of Adhulsa lozenges for pediatric patients. J. Drug Deliv. Ther., 2019, 9(2-s), 115-117.
[44]
Duryodhan, N.; Aparna, C.; Srinivas, P. Formulation and evaluation of medicated lozenges of albendazole for pediatrics use. Asian Journal of Biochemical and Pharmaceutical Research, 2015, 5(3), 202-215.